Advertisement
Life-Sciences-Europe.com
The European Life Sciences Web Portal
This is a free web portal for the life sciences in Europe and Israel... » read more
- Bruker Acquires Clinical Metagenomics Platform from Noscendo (2026-07-15)
Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of the DISQVER® clinical metagenomics platform from Noscendo GmbH. [ The DISQVER® platform provides advanced bioinformatics and reporting to support rapid and comprehensive WGS analysis direct... - Amiprox: Filter Plate for Sampleprep in Proteomics Workflows (2026-07-14)
> The only dedicated 96-deepwell filter plate on the market for direct, high-throughput depletion of human serum albumin and immunoglobulin G from plasma samples > ProtiPlate Pop2 plate offers depletion of HSA and IgG with over 97% efficiency Amiprox trans... - Formycon and OneSource Partner for Biosimilar Manufacturing (2026-07-14)
Formycon AG (FSE: FYB, Prime Standard, “Formycon”) and OneSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE, “OneSource”), a multi-modality specialty pharma CDMO, today announced a strategic manufacturing partnership for biosimilars. Under the... - Element Bio Prevails in German Patent Case Against Illumina (2026-07-14)
Munich Regional Court finds Illumina infringes Element sequencing intellectual property, enjoins supply of Illumina systems and related consumables, and orders recall of affected devices Element Biosciences, Inc. today announced that the Regional Court of Muni... - Evonik and Evitria to Accelerate Early Biologics Development (2026-07-14)
> New ready-to-use protein expression kit now available > eviCHO Expression Kit simplifies transient protein expression workflows and enables faster, more reliable protein production > Strengthens Evonik’s growth field Advance Precision Biosolutions Ev... - Caixa Capital Risc Rebrands as Criteria Capital Risc (2026-07-13)
> Caixa Capital Risc, a CriteriaCaixa venture capital management company, rebrands as Criteria Capital Risc > CriteriaCaixa targeting investment of €300 million within its 2030 Strategic Plan via two funds: Criteria Bio Ventures and Criteria Venture Tech ... - Innexis to Acquire Parts of Austrian Campus from Novartis (2026-07-09)
> INNEXIS plans to acquire a multi-user site from Novartis in Kundl including certain infrastructure facilities and real estate business services. As part of the transaction, 30 employees will be transferred to INNEXIS. > With this move, the internationally acti... - Evonik Invests $100m in US Drug Contract Manufacturing Site (2026-07-08)
> Meets the growing demand for U.S.-based contract development and manufacturing organizations (CDMOs) > Further improves capabilities to handle increasing complexity of active pharmaceutical ingredients (APIs) > Important step in Evonik’s asset balancing s... - Ottobock Acquires Fesia Technology, S.L., Spain (2026-07-07)
> Strategic expansion of the product portfolio in Functional Electrical Stimulation (FES) for neuro-orthotics > Functional Electrical Stimulation supports the restoration of functional movement in a wide range of neurological conditions Ottobock SE & Co. KG... - Myricx Bio to Be Acquired by Novartis for up to $1.5b (2026-07-06)
> Potential first-in-class N-myristoyltransferase inhibitor (NMTi) ADC payload with a differentiated mechanism of action > Combines oncology expertise of Novartis with Myricx Bio’s novel ADC assets and platform having broad potential across multiple solid tumo...
Life-Sciences-Europe.com is your doorway to the European life sciences!
[LSE] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!
» Start here with the latest News!Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)


![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)


